In last trading session, Gossamer Bio Inc (NASDAQ:GOSS) saw 2.1 million shares changing hands with its beta currently measuring 1.93. Company’s recent per share price level of $1.53 trading at $0.11 or 7.75% at ring of the bell on the day assigns it a market valuation of $346.71M. That closing price of GOSS’s stock is at a discount of -4.58% from its 52-week high price of $1.60 and is indicating a premium of 67.32% from its 52-week low price of $0.50.
For Gossamer Bio Inc (GOSS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.17 in the current quarter.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Upright in the green during last session for gaining 7.75%, in the last five days GOSS remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $1.53 price level, adding 1.29% to its value on the day. Gossamer Bio Inc’s shares saw a change of 69.14% in year-to-date performance and have moved 20.47% in past 5-day. Gossamer Bio Inc (NASDAQ:GOSS) showed a performance of 65.94% in past 30-days.
Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a rise of 61.75% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -30.72% in reaching the projected high whereas dropping to the targeted low would mean a loss of -30.72% for stock’s current value.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 7.02M for the same. And 6 analysts are in estimates of company making revenue of 3.48M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 11.99% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 76.06% while estimates for its earnings growth in next 5 years are of 26.42%.
Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders
NEA MANAGEMENT COMPANY, LLC is the top institutional holder at GOSS for having 18.09 million shares of worth $16.3 million. And as of 2024-06-30, it was holding 7.9979 of the company’s outstanding shares.
The second largest institutional holder is ARTAL GROUP S.A., which was holding about 13.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.8832 of outstanding shares, having a total worth of $11.99 million.
